Prospective Neodent® Zirconia System Study
Prospective Study of Neodent® Implantable Devices of Zirconia System
1 other identifier
observational
36
1 country
1
Brief Summary
The Neodent® Zirconia Implant is designed for the treatment of oral endosteal implantation for the functional and aesthetic rehabilitation, allowing for treatment of patients with different bone qualities. The objective of the study is to assess the success and survival rates of implantable devices of the Zirconia System, in order to confirm the long-term safety and clinical performance of implants and abutments of the Zirconia System in daily dental practice setting. Devices will be used according to standard routine in daily practice, according to manufacturer indications in the IFU. Patients will be followed for 36 months after implant placement.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Sep 2020
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 4, 2020
CompletedStudy Start
First participant enrolled
September 10, 2020
CompletedFirst Posted
Study publicly available on registry
September 11, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2024
CompletedNovember 9, 2023
November 1, 2023
3.1 years
September 4, 2020
November 8, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Implant survival rate
Implant survival will be defined as no loss of the implant.
36 months after implant placement
Implant success rate
Evaluation of implant success will be assessed based on the criteria proposed by Buser et al. (1990).
36 months after implant placement
Secondary Outcomes (7)
Implant survival rate
6 months after implant placement
Implant success rate
6 months after implant placement
Prosthetic survival rate
36 months after implant placement
Prosthetic success rate
36 months after implant placement
Patient satisfaction: questionnaire
At screening visit, after the temporary prosthesis period and 6, 12, 24 and 36 months after implant placement
- +2 more secondary outcomes
Study Arms (1)
Study group
Zirconia Implants will be placed. More than one implant can be placed in the same patient, as long as the subject presents natural teeth adjacent to the implant site.
Interventions
Dental Implants will be used according to standard routine in daily practice, according to all indications as specified by the manufacturer in the IFU (informations for use).
Eligibility Criteria
Patients 18 years of age or older who are in need of and who qualify for single dental implants placement in the posterior maxilla region with Neodent® Zirconia Implants. Patients that give written informed consent to participate in this clinical study.
You may qualify if:
- years of age or older;
- Maxillary posterior teeth missing, with adjacent natural teeth;
- Patient who are in need of oral rehabilitation with dental implants and single prostheses and qualify for placement of Zirconia Implants.
You may not qualify if:
- Subjects under 18 years of age, pregnant or breastfeeding women. And patients that present the device contraindications according to the IFU (instructions for use):
- Signs of allergy or hypersensitivity to the chemical ingredients of the material: Zirconia (Y-ZTP), Zirconium dioxide (ZrO2), Yttrium oxide (Y2O3), Hafnium dioxide (HfO2), Aluminum oxide (Al2O3);
- Acute inflammatory or infectious processes;
- Unsuitable bone volume or quality;
- Serious medical problems (e.g. bone metabolism disorders, blood clotting disorders, unsuitable healing capacity);
- Incomplete jawbone growth;
- Patient uncooperative and not motivated;
- Hypochondria;
- Alcoholism;
- Psychosis;
- Prolonged functional disorders which resist any treatment with medications;
- Xerostomia;
- Weakened immunological system;
- Diseases which require regular use of steroids;
- Uncontrolled endocrine diseases;
- +2 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Neodentlead
Study Sites (1)
Instituto Latino Americano de Pesquisa e Ensino Odontológico (ILAPEO)
Curitiba, Paraná, 80710-150, Brazil
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Larissa Trojan, PhD
Neodent
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 4, 2020
First Posted
September 11, 2020
Study Start
September 10, 2020
Primary Completion
September 30, 2023
Study Completion
December 30, 2024
Last Updated
November 9, 2023
Record last verified: 2023-11
Data Sharing
- IPD Sharing
- Will not share